Cannabinoids for Behavioral Problems in Children With ASD
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the safety, tolerability and efficacy of cannabinoids mix
[cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) in a 20:1 ratio, BOL Pharma, Israel] for
behavioral problems in children and youth with ASD.